Total Payments
$39,992
2024 Payments
$39,324
Companies
19
Transactions
45
Medicare Patients
1,477
Medicare Billing
$208,343
Payment Breakdown by Category
Consulting$38,238 (95.6%)
Food & Beverage$1,474 (3.7%)
Travel$280.63 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,238 | 2 | 95.6% |
| Food and Beverage | $1,474 | 41 | 3.7% |
| Travel and Lodging | $280.63 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $38,808 | 13 | $0 (2024) |
| Telix Pharmaceuticals | $558.43 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $154.14 | 3 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $56.52 | 1 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $51.26 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $47.30 | 3 | $0 (2023) |
| Boston Scientific Corporation | $35.61 | 2 | $0 (2019) |
| Daiichi Sankyo Inc. | $34.89 | 2 | $0 (2023) |
| EMD Serono, Inc. | $34.74 | 1 | $0 (2024) |
| Augmenix, Inc. | $33.72 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,324 | 21 | Novartis Pharmaceuticals Corporation ($38,728) |
| 2023 | $305.98 | 8 | Telix Pharmaceuticals ($152.55) |
| 2022 | $96.37 | 6 | Novartis Pharmaceuticals Corporation ($33.11) |
| 2019 | $119.40 | 7 | Boston Scientific Corporation ($35.61) |
| 2018 | $146.36 | 3 | Merck Sharp & Dohme Corporation ($112.64) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/10/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $139.86 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/16/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $139.39 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $34,437.50 | General |
| 11/06/2024 | Siemens Medical Solutions USA, Inc. | ARIA Radiation Therapy Management Software (Device) | Food and Beverage | In-kind items and services | $56.52 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/30/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $41.01 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/28/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $262.49 | General |
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.33 | General |
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $18.14 | General |
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
| 05/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $34.74 | General |
| 05/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/09/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $187.54 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 03/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Oncology | ||||||
| 11/20/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/08/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Oncology | ||||||
| 10/25/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological), DARZALEX | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Oncology | ||||||
| 10/02/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $47.47 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 369 | 733 | $130,541 | $42,845 |
| 2022 | 13 | 438 | 885 | $235,272 | $66,343 |
| 2021 | 13 | 404 | 900 | $206,303 | $58,825 |
| 2020 | 12 | 266 | 652 | $107,850 | $40,330 |
Total Patients
1,477
Total Services
3,170
Medicare Billing
$208,343
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 30 | 72 | $30,064 | $10,526 | 35.0% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 32 | 128 | $16,512 | $5,918 | 35.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 55 | 163 | $23,309 | $5,526 | 23.7% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 25 | 26 | $13,078 | $4,497 | 34.4% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 33 | 35 | $13,111 | $4,444 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 27 | 27 | $9,436 | $3,726 | 39.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 30 | 110 | $8,250 | $2,779 | 33.7% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 26 | 27 | $4,983 | $1,707 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 36 | $5,144 | $1,498 | 29.1% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 27 | 51 | $2,295 | $787.00 | 34.3% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 23 | 25 | $2,075 | $727.75 | 35.1% |
| 77332 | Design and construction of simple radiation treatment device | Facility | 2023 | 19 | 21 | $1,193 | $384.93 | 32.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 12 | 12 | $1,091 | $325.32 | 29.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 28 | 64 | $26,240 | $9,227 | 35.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 29 | 132 | $16,899 | $6,149 | 36.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 12 | 37 | $27,750 | $5,423 | 19.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 54 | 135 | $12,915 | $4,659 | 36.1% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2022 | 13 | 13 | $14,000 | $4,464 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $10,045 | $4,239 | 42.2% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 23 | 24 | $11,451 | $4,177 | 36.5% |
| 77295 | 3d radiation therapy planning | Office | 2022 | 11 | 11 | $25,135 | $3,947 | 15.7% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 28 | 29 | $10,672 | $3,667 | 34.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2022 | 13 | 36 | $21,600 | $3,376 | 15.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2022 | 14 | 61 | $17,385 | $3,005 | 17.3% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 31 | 111 | $7,992 | $2,787 | 34.9% |
About Dr. Dustin Boothe, MD
Dr. Dustin Boothe, MD is a Radiation Oncology healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1700128154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dustin Boothe, MD has received a total of $39,992 in payments from pharmaceutical and medical device companies, with $39,324 received in 2024. These payments were reported across 45 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($38,238).
As a Medicare-enrolled provider, Boothe has provided services to 1,477 Medicare beneficiaries, totaling 3,170 services with total Medicare billing of $208,343. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Greeley, CO
- Active Since 03/25/2013
- Last Updated 07/14/2018
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700128154
Products in Payments
- ILLUCCIX (Drug) $558.43
- LUTATHERA (Drug) $175.04
- KEYTRUDA (Biological) $154.14
- PLUVICTO (Drug) $56.65
- ARIA Radiation Therapy Management Software (Device) $56.52
- PYLARIFY (Drug) $51.26
- Xofigo (Drug) $47.30
- GENERAL THERAPIES (Device) $35.61
- SpaceOAR (Device) $33.72
- TECVAYLI (Biological) $23.43
- Oncology (Device) $22.89
- NINLARO (Drug) $20.30
- Empaveli (Drug) $20.11
- ENHERTU (Drug) $19.97
- Tavalisse (Drug) $19.53
- Nplate (Biological) $16.53
- INJECTAFER (Drug) $14.92
- KISQALI (Drug) $13.72
- TUKYSA (Drug) $12.85
- JEVTANA (Drug) $11.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.